PATENT CLAIM ANALYSIS

Application Number: 15881300
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-06
Patent Classification: ["424", "450000"]

Abstract:
Compositions and methods are provided including a transporter peptide derived from the loop2 domain of the neuronally-derived lynx protein which can be conjugated to an effector agent to form a transporter-effector complex for transport of the therapeutic effector agent to a target that is found across the blood brain barrier.

Claim (Index 19):
The method of  claim 9 , wherein the composition is a pharmaceutical composition.

Metadata:
- Claim Count in Document: 9.0
- Percentile: 86.0
- Lexical Diversity: 1.2439
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13487238', '15351024', '14101196', '12301847', '14265939']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.802444420732549
- 35 USC 102 Novelty (BERT): 0.6290858746575628
- Combined Prediction Score: 0.7851085661250503
- Mean Citation Score: 476.54719000000006
- Max Citation Score: 591.2656
- Similarity Product: 549.6396209311486

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test